Report cover image

U.S. Laparotomy Sponge Market Size, Share & Trends Analysis Report By Product (Radiopaque Laparotomy Sponge, Traditional Laparotomy Sponge, Radio-frequency Identification Laparotomy Sponge), By End-use (Hospitals & Clinics), And Segment Forecasts, 2025 -

Published Aug 11, 2025
Length 125 Pages
SKU # GV20399953

Description

U.S. Laparotomy Sponge Market Trends

The U.S. laparotomy sponge market size was valued at USD 422.7 million in 2024 and is projected to reach USD 706.9 million by 2033, growing at a CAGR of 5.9% from 2025 to 2033. Key factors driving growth include a rise in abdominal surgeries due to conditions such as cancer and hernias, as well as an increase in C-sections. Demand is further enhanced by concerns regarding retained surgical items, which have led to the adoption of radiopaque and RFID-enabled sponges. Additionally, the growth is fueled by the aging population, increased surgical volumes in outpatient settings, and advancements in sponge design and materials, all supported by regulatory emphasis on surgical safety and infection control.

Additionally, the U.S. is witnessing heightened focus on surgical safety, particularly in preventing retained surgical items (RSIs). RSIs, especially sponges, are among the most common and dangerous surgical errors, leading to severe complications, repeat surgeries, infections, and even fatalities. For instance, according to the National Quality Forum (NQF), 2,000-4,000 cases of retained surgical items (RSIs) are reported yearly in the U.S., where sponges are the most frequently retained objects.

Laparotomy sponges are used in sterile, high-bleeding-risk operations, including resections. According to the American Cancer Society, approximately 106,180 new colorectal cases were recorded in the U.S., many of which require open (laparotomy) procedures, where sponges are essential for fluid management and tissue retraction.

Sustainability, ergonomic design, and targeted customization are emerging as influential factors in the evolution of laparotomy sponges in the U.S. healthcare market. As hospitals increasingly prioritize environmentally responsible procurement, manufacturers are responding by developing laparotomy sponges made with eco-friendly materials, reduced packaging waste, and biodegradable components. These innovations align with broader institutional goals of lowering medical waste and achieving greener operating room practices. In a market that has historically focused on functionality and cost, sustainability is now becoming a competitive differentiator, especially among large hospital systems aiming to meet ESG (Environmental, Social, and Governance) targets.

In parallel, ergonomic design and procedure-specific customization are enhancing surgical efficiency and safety. Modern laparotomy sponges are being developed with features such as reinforced edges for easier retrieval, improved texture for better fluid absorption, and color-coded systems to assist in intraoperative tracking. Some products are even customized based on surgical specialty-such as gynecologic oncology or trauma care, ensuring optimal size, shape, and absorbency for the intended use.

U.S. Laparotomy Sponge Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. laparotomy sponge market report based on product and end-use:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiopaque Laparotomy Sponge
  • Traditional Laparotomy Sponge
  • Radio-frequency Identification (RFID) Laparotomy Sponge
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Others
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

125 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. U.S. Laparotomy Sponge Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising number of laparotomy surgeries
3.2.1.2. Growing prevalence of abdominal disorders
3.2.1.3. Growing geriatric population
3.2.1.4. Advancements in surgical safety regulations
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of laparotomy sponges
3.3. Laparotomy Sponge Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. U.S. Laparotomy Sponge Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Laparotomy Sponge Market: Product Movement Analysis
4.3. Laparotomy Sponge Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Radiopaque Laparotomy Sponge
4.5.1. Radiopaque Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Traditional Laparotomy Sponge
4.6.1. Traditional Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Radio-frequency Identification (RFID) Laparotomy Sponge
4.7.1. Radio-frequency Identification (RFID) Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Laparotomy Sponge Market: End-use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Laparotomy Sponge Market: End-use Movement Analysis
5.3. Laparotomy Sponge Market by End-use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Hospitals & Clinics
5.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Market Participant Categorization
6.2. Key Company Profiles
6.2.1. Integra LifeSciences
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Medical Action Industries Inc.
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. SDP Inc.
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Dukal, LLC
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Stryker
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Cardinal Health
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. AllCare
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. DeRoyal Industries Inc.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Allmed Medical Products Co.,Ltd.
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Premier Enterprises
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.